Derivatives industry veteran Leo Melamed will retire from the CME Group board of directors, where is serving as chairman emeritus, at the conclusion of his current term in May 2018, officials say. After his retirement, Melamed will act as a consultant to the CME Group for the next two years. “After that time, Melamed will… Read More >>